Hydroxychloroquine did not lower the risk of dying or needing a breathing tube in a comparison that involved nearly 1,400 patients treated at Columbia University in New York, researchers reported.
A study of nearly 1,400 patients with moderate to severe COVID-19 disease found that patients who received the drug did not fare any better than patients who did not receive the drug.
New modeling projections by scientists at the Mailman School of Public Health estimate that COVID-19 cases and deaths will rebound in late May as U.S. states ease stay-at-home orders.
In this first installment of a series of personal accounts from Columbians on the front line of the COVID-19 pandemic, three CUIMC faculty relay what they’re witnessing and what worries them.
Columbia University has launched the COVID-19 Healthcare Personnel Study to assess the impact of the COVID-19 pandemic on the physical and mental health of hospital workers in New York state.
While some of the children with this condition do end up with respiratory problems, “it seems to be less a lung-specific disease,” said Dr. Steven Kernie, chief of pediatric critical care at Columbia.
Dr. Rachel Easterwood, a professionally trained musician-turned-physician, has found a unique way to help her patients with Covid-19 — live classical music concerts.
